Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
gptkb:multiple_sclerosis_subtype |
| gptkbp:abbreviation |
gptkb:PPMS
|
| gptkbp:affects |
central nervous system
|
| gptkbp:causedBy |
gptkb:unknown
|
| gptkbp:firstDescribed |
1970s
|
| gptkbp:hasOnsetAge |
usually after age 40
|
| gptkbp:offersCourse |
steady progression without relapses
|
| gptkbp:prevalence |
about 10-15% of MS cases
|
| gptkbp:prognosis |
generally worse than relapsing-remitting MS
|
| gptkbp:riskFactor |
age
genetics environmental factors |
| gptkbp:subspecies |
multiple sclerosis
|
| gptkbp:symptom |
balance problems
muscle weakness spasticity bladder dysfunction cognitive impairment progressive neurological disability walking difficulties |
| gptkbp:treatment |
gptkb:ocrelizumab
physical therapy symptomatic management |
| gptkbp:bfsParent |
gptkb:Multiple_Sclerosis
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
primary progressive MS
|